News archive search
Search the Newsreel
Search stored headlines and summaries, then narrow the results by company, country, sector, industry, source or date.
- Showing
- 73–108
- Matches
- 209
- Sources here
- 20
- Companies here
- 9
Active search
209 matching headlines
Search results
Matching headlines
External headlines link to their original source. Market context comes from stored weekly company data, not from an opinion about the article.
Labcorp Holdings Inc. stock rises Tuesday, still underperforms market
Labcorp Holdings Inc. (LH) stock increased by 1.60% on Tuesday, closing at $312.34. Despite this rise, the stock still underperformed the broader market, as both the S&P 500 Index and the Dow Jones Industrial Average saw larger gains. This marked the end of a …
Labcorp Test May Identify Prostate Cancer Patients for TRUQAP
Labcorp (NYSE: LH) has announced the nationwide availability of Roche's VENTANA PTEN (SP218) RxDx Assay, the first FDA-approved immunohistochemistry companion diagnostic for prostate adenocarcinoma. This test identifies PTEN protein loss in tumors, helping to determine which patients may be eligible for combination treatment with …
DLHC|DLH Holdings Corp|Price:5.025|Chg%:+0.145
This article provides a comprehensive stock analysis of DLH Holdings Corp (DLHC) from TradingKey, highlighting its stable fundamentals, good growth potential, and fair valuation within the Software & IT Services industry. Despite high institutional ownership and analyst "Buy" ratings, the stock is expected to …
How Valhi Inc. (VHI) Affects Rotational Strategy Timing
The article analyzes Valhi Inc. (VHI) with a neutral sentiment across all time horizons, suggesting a wait-and-see approach. It highlights resistance testing and provides institutional trading strategies, including position, momentum breakout, and risk hedging, along with detailed signal analysis and risk-reward ratios. The report …
DLH Holdings Corp. 2026: Revenue $44.23M, EPS ($1.16) — 10-Q Summary
DLH Holdings Corp. reported a significant decline in its financial results for the quarter ended 2026, with revenue decreasing by 46.9% to $44.23M and a net loss of $16.79M, or ($1.16) diluted EPS, compared to a net income in the prior year. This downturn …
The Bull Case For Labcorp (LH) Could Change Following Guidance Hike And New Genetic Panel Launch
Labcorp Holdings Inc. reported strong Q2 and first-half results, raising its 2026 revenue growth guidance to 5.4%–6.3%, and completed a significant share repurchase program. The company also launched its new Marker by Labcorp Genetic Health Panel, a direct-to-consumer genetic testing service, which is expected …
DLH Holdings Corp. 2026 Q3 - Results - Earnings Call Presentation (NASDAQ:DLHC) 2026-08-01
DLH Holdings Corp. (DLHC) has published its Q3 2026 earnings call presentation. The company reported an EPS of -$0.93, missing estimates by $0.76, and revenue of $44.23 million, a 46.94% year-over-year decrease, missing estimates by $5.78 million. This information was released in conjunction with …
Mink Brook Asset Management acquires $51,083 of DLH Holdings stock
Mink Brook Asset Management LLC, a director and 10% owner of DLH Holdings Corp. (NASDAQ:DLHC), recently acquired 10,000 shares of the company's common stock for $51,083. These purchases occurred on July 9 and July 10, 2026, when the stock was trading near its 52-week …
DLH Holdings (NASDAQ: DLHC) holder buys 4,407 shares, updates stake
Mink Brook Asset Management LLC, a ten percent owner of DLH Holdings Corp. (NASDAQ: DLHC), reported an open-market purchase of 4,407 shares of common stock on July 13, 2026, at a weighted average price of $5.0926 per share. This transaction updates its stake to …
DLH Holdings: Mink Brook Asset Management, 10% owner, buys $77,534 stock
Mink Brook Asset Management LLC, a 10% owner of DLH Holdings Corp. (NASDAQ:DLHC), recently purchased an additional $77,534 worth of stock on July 2 and July 6, 2026. The acquisition involved 14,882 shares at weighted average prices between $5.1881 and $5.2477. This comes after …
DLH Holdings Corp. (DLHC) fund reports 470-share insider purchase
Mink Brook Asset Management LLC, a 10% owner of DLH Holdings Corp. (DLHC), reported an indirect purchase of 470 common shares through Mink Brook Partners LP. These transactions occurred on July 23-24, 2026, at weighted-average prices between $5.08 and $5.10 per share. The amended …
Mink Brook adds 14,882 DLH Holdings Corp. (DLHC) shares in July buys
Mink Brook Asset Management LLC, a 10% owner of DLH Holdings Corp. (DLHC), indirectly purchased a total of 14,882 shares of common stock through Mink Brook Partners LP in two separate transactions in July 2026. The purchases, on July 2nd and July 6th, involved …
Form 4 DLH Holdings Corp For: 31 July By Investing.com
This article reports on a Form 4 filing for DLH Holdings Corp (NASDAQ:DLHC) as of July 31. Form 4 filings are regulatory documents that disclose changes in ownership of company stock by insiders. The article provides the title of the filing and indicates it …
Insider Buying: DLH (NASDAQ:DLHC) Major Shareholder Acquires $39,402.24 in Stock
Mink Brook Asset Management, a major shareholder in DLH Holdings Corp. (NASDAQ:DLHC), recently purchased 7,944 shares totaling $39,402.24, increasing its stake by 0.37%. This transaction, along with several others in July, occurred as DLH shares traded near their one-year low. The company reported a …
Labcorp (LH) Launches Marker Genetic Health Panel For Consumer Testing
Labcorp (LH) has introduced the Marker by Labcorp Genetic Health Panel, a new consumer-focused genetic testing service that combines genetic testing, counseling, and biomarker analysis. This launch integrates Labcorp's existing infrastructure with new AI-powered platforms to provide tailored health insights. The company's stock has …
LH Q2 Deep Dive: Specialty Testing and Consumer Growth Drive Guidance Increase
LH Q2 Deep Dive: Specialty Testing and Consumer Growth Drive Guidance Increase Healthcare diagnostics company Labcorp Holdings (NYSE:LH) met Wall Street's revenue expectations in Q2 CY2026, with sales up 5.8% year on year to $3.73 billion. The company's outlook for the full year was …
Labcorp (LH) Stock Holds A Bullish Case On Margin Expansion
Labcorp (LH) reported strong Q2 2026 earnings with increased revenue and basic EPS, and significant margin expansion, with net margin rising to 7% from 5.7% a year prior. Management also raised its full-year revenue and adjusted EPS guidance, indicating a steady bullish trend despite …
DLH Holdings Corp. (DLHC) insider buys 7,275 additional shares
Mink Brook Asset Management LLC, a 10% owner of DLH Holdings Corp. (DLHC), reported open-market purchases of 7,275 shares of Common Stock on July 7–8, 2026. These transactions, reported in an amended Form 4 to correct a mathematical error, were made at weighted-average prices …
Mink Brook fund buys 10,000 DLH Holdings Corp. (DLHC) shares
Mink Brook Asset Management LLC, managing the Mink Brook Partners LP investment fund, reported indirect purchases of 10,000 shares of DLH Holdings Corp. (DLHC) common stock. These open-market transactions occurred on July 9-10, 2026, at weighted average prices of $5.1255 and $5.0912 per share, …
Labcorp Holdings Inc. stock underperforms Friday when compared to competitors
Labcorp Holdings Inc. (LH) stock fell 2.01% on Friday, closing at $309.20, despite a positive trading session for the broader market with the S&P 500 and Dow Jones Industrial Average both rising. The company's shares ended 2.19% below its 52-week high of $316.11, which …
Labcorp (LH) Stock Looks Cheap On Cash Flow While Earnings Look Full
Labcorp (LH) stock shows mixed valuation signals; its Discounted Cash Flow (DCF) model suggests it's 44.1% undervalued, while its P/E ratio indicates it's overvalued compared to earnings-based fair ratios. The company's recent launch of the Marker by Labcorp Genetic Health Panel could drive future …
Labcorp Q2 Earnings Call Highlights
Labcorp (LH) reported strong Q2 2026 results with a 5.8% revenue increase to $3.7 billion and a 14.9% rise in adjusted EPS to $4.99, leading the company to raise its full-year revenue and adjusted EPS guidance. Growth was driven by solid performance in its …
Rothschild & Co Redburn Adjusts Price Target on Labcorp Holdings to $385 From $325, Maintains Buy Rating
Rothschild & Co Redburn has increased its price target for Labcorp Holdings (NYSE:LH) to $385 from $325, while maintaining a Buy rating on the stock. This adjustment reflects a positive outlook on the company's financial prospects and market position.
Labcorp Q2 2026 slides: strong results drive guidance raise
Labcorp (NYSE:LH) reported strong Q2 2026 results, surpassing Wall Street expectations with adjusted earnings of $4.99 per share and revenue of $3.73 billion. This performance led the company to raise its full-year guidance for 2026. Key drivers included robust organic growth, operational efficiency gains, …
Labcorp Holdings Inc. Stock 12‑Month Price Target Raised to $317.31, Implies 3% Upside
Labcorp Holdings Inc. (LH) has seen its average 12-month price target raised to $317.31 from $313.56 by 16 analysts, implying a 3% potential upside from its July 29 closing price. The consensus rating for the stock remains a "Buy" among 22 covering analysts, with …
Labcorp Q2 2026 slides: revenue rises 5.8%, guidance lifted
Labcorp reported strong second-quarter 2026 results, with revenue increasing by 5.8% to $3.73 billion and adjusted operating income growing to $588.7 million. The company also lifted its full-year 2026 guidance for both revenue and adjusted earnings per share, driven by solid performance in both …
Labcorp Holdings Inc. stock outperforms competitors on strong trading day
Labcorp Holdings Inc. (LH) shares rose 2.73% to $315.53 on Thursday, outperforming the S&P 500 Index and the Dow Jones Industrial Average. The company closed just shy of its 52-week high of $315.77. This strong performance occurred during an overall positive trading session for …